Literature DB >> 9888024

Evolution of outpatient parenteral antibiotic therapy.

D M Poretz1.   

Abstract

The future will no doubt continue to promote safe, cost-effective therapies such as outpatient intravenous therapy. It is imperative that physicians trained and knowledgeable in the administration of outpatient intravenous antimicrobial drug administration continue to assume responsibility and leadership roles.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9888024     DOI： 10.1016/s0891-5520(05)70022-2

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN： 0891-5520            Impact factor:   5.982


  6 in total

1.  Outpatient parenteral antibiotic therapy in an academic practice in Rhode Island.

Authors:  Francine Touzard Romo; Brian Resnick; Mildred Perez-Cioe; Timothy P Flanigan; Erna M Kojic; Curt G Beckwith
Journal:  R I Med J (2013)       Date:  2014-01-05

2.  Comparative outcomes of β-lactam antibiotics in outpatient parenteral antibiotic therapy: treatment success, readmissions and antibiotic switches.

Authors:  Boeun Lee; Idy Tam; Bernard Weigel; Janis L Breeze; Jessica K Paulus; Jason Nelson; Genève M Allison
Journal:  J Antimicrob Chemother       Date:  2015-05-29       Impact factor: 5.790

Review 3.  Ambulatory use of parenteral antibacterials: contemporary perspectives.

Authors:  J E Leggett
Journal:  Drugs       Date:  2000       Impact factor: 9.546

4.  Value and Clinical Impact of an Infectious Disease-Supervised Outpatient Parenteral Antibiotic Therapy Program.

Authors:  Russell M Petrak; Nathan C Skorodin; Robert M Fliegelman; David W Hines; Vishnu V Chundi; Brian P Harting
Journal:  Open Forum Infect Dis       Date:  2016-10-19       Impact factor: 3.835

5.  Predictors of Unplanned Hospitalization in Patients Receiving Outpatient Parenteral Antimicrobial Therapy Across a Large Integrated Healthcare Network.

Authors:  Monica Schmidt; Bevin Hearn; Michael Gabriel; Melanie D Spencer; Lewis McCurdy
Journal:  Open Forum Infect Dis       Date:  2017-06-16       Impact factor: 3.835

6.  Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry.

Authors:  W J Martone; K C Lindfield; D E Katz
Journal:  Int J Clin Pract       Date:  2008-08       Impact factor: 2.503
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.